NewEdge Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.86M | Sell |
7,618
-1,690
| -18% | -$635K | 0.04% | 307 |
|
|
2025
Q1 | $4.51M | Sell |
9,308
-32,139
| -78% | -$15.6M | 0.08% | 197 |
|
|
2024
Q4 | $16.7M | Buy |
41,447
+1,297
| +3% | +$522K | 0.29% | 89 |
|
|
2024
Q3 | $18.7M | Buy |
40,150
+1,238
| +3% | +$576K | 0.34% | 77 |
|
|
2024
Q2 | $18.2M | Buy |
38,912
+4,245
| +12% | +$1.99M | 0.4% | 69 |
|
|
2024
Q1 | $13.9M | Buy |
34,667
+4,095
| +13% | +$1.64M | 0.31% | 88 |
|
|
2023
Q4 | $12.4M | Buy |
30,572
+3,478
| +13% | +$1.42M | 0.32% | 86 |
|
|
2023
Q3 | $9.42M | Buy |
27,094
+6,275
| +30% | +$2.18M | 0.3% | 94 |
|
|
2023
Q2 | $7.33M | Buy |
20,819
+206
| +1% | +$72.5K | 0.24% | 105 |
|
|
2023
Q1 | $6.49M | Buy |
20,613
+235
| +1% | +$74K | 0.25% | 99 |
|
|
2022
Q4 | $5.88M | Buy |
20,378
+17
| +0.1% | +$4.91K | 0.25% | 97 |
|
|
2022
Q3 | $5.9M | Buy |
20,361
+16,361
| +409% | +$4.74M | 0.28% | 93 |
|
|
2022
Q2 | $1.13M | Buy |
4,000
+1,632
| +69% | +$460K | 0.05% | 275 |
|
|
2022
Q1 | $618K | Buy |
+2,368
| New | +$618K | 0.03% | 275 |
|